Abstract
Familial defective apolipoprotein B-100 (FDB) is an autosomal codominant disorder associated with hypercholesterolemia, caused by mutations in and around codon 3500 of the Apolipoprotein (Apo) B gene, which encodes Apo B-100. The first mutation occurred in Arginine codons to be described, and the most characterized, is caused by a G→A transition at nucleotide 10,708 leading to the substitution of Arginine by Glutamine at codon 3500 (ApoB R3500Q). In this study, we have applied PCR-Sequencing to identify 27/40 R3500Q mutations in known FDB patients, counting for 68%, in which, most of the patients carried heterozygous mutation R3500Q, 25/27 cases. PCR-Sequencing method that we have applied for this study proved consistent and fast method to identify mutations correctly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34–47
Choong ML, Koay ES, Khoo KL, Khaw MC, Sethi SK (1997) Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500 →tryptophan mutation associated with a unique haplotype. Clin Chem 43(6 Pt 1):916–923
Dedoussis GV, Genschel J, Bochow B, Pitsavos C, Skoumas J, Prassa M, Lkhagvasuren S, Toutouzas P, Vogt A, Kassner U, Thomas HP, Schmidt H (2004) Molecular characterization of familial hypercholesterolemia in German and Greek patients. Hum Mutat 23(3):285–286
Fisher E, Scharnagl H, Hoffmann MM, Kusterer K, Wittmann D, Wieland H, Gross W, März W (1999) Mutations in the apolipoprotein (apo) B-100 receptor-binding region: detection of apo B-100 (Arg3500→Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405→Gln) diminishes receptor-mediated uptake of LDL. Clin Chem 45(7):1026–1038
Friedl W, Ludwig EH, Balestra ME, Arnold KS, Paulweber B, Sandhofer F, McCarthy BJ, Innerarity TL (1991) Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred. Arterioscler Thromb 11(2):371–378
Futema M, Plagnol V, Whittall RA, Neil HA (2012) Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia. J Med Genet 49(10):644–649
Futema M, Whittall RA, Kiley A, Steel LK, Cooper JA, Badmus E, Leigh SE, Karpe F, Neil HA, Simon Broome Register Group, Humphries SE (2013) Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic. Atherosclerosis 229(1):161–168
García-García AB, Real JT, Puig O, Cebolla E, Marín-García P, Martínez Ferrandis JI, García-Sogo M, Civera M, Ascaso JF, Carmena R, Armengod ME, Chaves FJ (2001) Molecular genetics of familial hypercholesterolemia in Spain: ten novel LDLR mutations and population analysis. Hum Mutat 18(5):458–459
Heath KE, Humphries SE, Middleton-Price H, Boxer M (2001) A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom. Eur J Hum Genet 9(4):244–252
Henderson BG, Wenham PR, Ashby JP, Blundell G (1997) Detecting familial defective apolipoprotein B-100: three molecular scanning methods compared. Clin Chem 43(9):1630–1634
Hevonoja T, Pentikäinen MO, Hyvönen MT, Kovanen PT, Ala-Korpela M (2000) Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim Biophys Acta 1488(3):189–210
Horvath A, Savov A, Kirov S, Karshelova E, Paskaleva I, Goudev A, Ganev V (2001) High frequency of the ApoB-100 R3500Q mutation in Bulgarian hypercholesterolaemic subjects. J Med Genet 38(8):536–540
Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL (1990) Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolaemia. J Lipid Res 31(8):1337–1349
Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C; French ADH Research Network, Boileau C, Varret M, Rabès JP (2010) Molecular spectrum of autosomal dominant hypercholesterolemia in France. Hum Mutat 31(11):E1811–E1824
Myant NB (1993) Familial defective apolipoprotein B-100: including some comparisons with familial hypercholesterolaemia. Atherosclerosis 104(1–2):1–18
Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP (1995) Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 95(3):1225–1234
Rabès JP, Varret M, Devillers M, Aegerter P, Villéger L, Krempf M, Junien C, Boileau C (2000) R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia. Arterioscler Thromb Vasc Biol 20(10):E76–E82
Real JT, Chaves FJ, Ejarque I, García-García AB, Valldecabres C, Ascaso JF, Armengod ME, Carmena R (2003) Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population. Eur J Hum Genet 11(12):959–965
Tai DY, Pan JP, Lee-Chen GJ (1998) Identification and haplotype analysis of apolipoprotein B-100 Arg3500→Trp mutation in hyperlipidemic Chinese. Clin Chem 44(8 Pt 1):1659–1665
Tai ES, Koay ES, Chan E, Seng TJ, Loh LM, Sethi SK, Tan CE (2001) Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia. Clin Chem 47(3):438–443
Thiart R, Scholtz CL, Vergotine J, Hoogendijk CF, de Villiers JN, Nissen H, Brusgaard K, Gaffney D, Hoffs MS, Vermaak WJ, Kotze MJ (2000) Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia. J Med Genet 37(7):514–519
Thomas ER, Atanur SS, Norsworthy PJ, Encheva V, Snijders AP, Game L, Vandrovcova J, Siddiq A, Seed M, Soutar AK, Aitman TJ (2013) Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia. Mol Genet Genomic Med 1(3):155–161
Tybjaerg-Hansen A, Humphries SE (1992) Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolaemia and premature coronary artery disease. Atherosclerosis 96(2–3):91–107
Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG (1998) Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med 338(22):1577–1584
Wang J, Ban MR, Hegele RA (2005) Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia. J Lipid Res 46(2):366–372
Acknowledgements
This work was supported by Ho Chi Minh City Open University Fund. The assistance of the Xuyen A Hospital and Thu Duc Hospital, Vietnam, are also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Truong, P.K., Van Bui, C., Lao, T.D., Le, T.H.A. (2018). Detection of Defective Apolipoprotein B-100 R3500Q Mutation Caused Familial Hypercholesterolemia in Vietnamese Patients. In: Vo Van, T., Nguyen Le, T., Nguyen Duc, T. (eds) 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6) . BME 2017. IFMBE Proceedings, vol 63. Springer, Singapore. https://doi.org/10.1007/978-981-10-4361-1_46
Download citation
DOI: https://doi.org/10.1007/978-981-10-4361-1_46
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4360-4
Online ISBN: 978-981-10-4361-1
eBook Packages: EngineeringEngineering (R0)